Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
08/29/2012 | CN101985623B Cloning and application of key gene Wo for controlling tomato hair generation |
08/29/2012 | CN101948521B Recombinant antigenic protein for diagnosing echinococcosis granulosus, preparation method thereof and use thereof |
08/29/2012 | CN101798597B Assistant identification method of wheat with advanced characters |
08/29/2012 | CN101701033B Methods for preparing antigen, antibody and sample of Eperythrozoon suis |
08/29/2012 | CN101659695B O-type aftosa synthetic peptide vaccine |
08/29/2012 | CN101386646B Plant salt stress tolerant protein and encoding gene and application thereof |
08/29/2012 | CN101330927B Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
08/29/2012 | CN101307105B Human parathyroid hormone 1-34 peptide analogue capable of expressing in series and being released by synchronousacid hydrolysis, preparation method thereof and use |
08/29/2012 | CN101108878B Glp-1 analogues |
08/29/2012 | CN101056987B Bioactive compositions, natural methods of producing them and computational methods for designing natural production processes |
08/29/2012 | CN101052708B Serum-free cell culture medium for mammalian cells |
08/28/2012 | US8252979 Manipulation of ammonium transporters (AMTS) to improve nitrogen use efficiency in higher plants |
08/28/2012 | US8252978 Shine clade of transcription factors and their use |
08/28/2012 | US8252974 Precise breeding—low acrylamide foods |
08/28/2012 | US8252923 Peptidomimetic protease inhibitors |
08/28/2012 | US8252916 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
08/28/2012 | US8252915 Human transferase family members and uses thereof |
08/28/2012 | US8252906 Anti-herpes simplex virus antibodies and methods of use thereof |
08/28/2012 | US8252904 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
08/28/2012 | US8252901 Membrane fusion proteins derived from reovirus |
08/28/2012 | US8252899 Methods and compositions for obtaining high-resolution crystals of membrane proteins |
08/28/2012 | US8252898 Defensin-encoding nucleic acid molecules derived from Nicotiana alata, uses therefor and transgenic plants comprising same |
08/28/2012 | US8252894 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
08/28/2012 | US8252893 CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof |
08/28/2012 | US8252743 Modified erythropoietin polypeptides and uses thereof for treatment |
08/28/2012 | US8252740 Thermally-targeted delivery of medicaments including doxorubicin |
08/28/2012 | US8252739 Albumin fusion proteins |
08/28/2012 | US8252584 Adiponectin receptor and gene encoding the same |
08/28/2012 | US8252580 Transgenic escherichia for use as bioreactor in propagation of amidated peptides |
08/28/2012 | US8252578 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
08/28/2012 | US8252573 Alpha-amylase variant with altered properties |
08/28/2012 | US8252572 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
08/28/2012 | US8252552 and processing of transgenic sugarcane for the recovery of high value proteins; using a nucleic acid encoding the promoter of a sugarcane proline rich protein |
08/28/2012 | US8252547 In vitro control of protein synthesis in mammalian cells by IP3 receptor-binding protein |
08/28/2012 | US8252545 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
08/28/2012 | US8252529 Methods for collecting and detecting oligonucleotides |
08/28/2012 | US8252528 Methods, compositions, and kits for collecting and detecting oligonucleotides |
08/28/2012 | US8252520 Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases |
08/28/2012 | US8252338 Synthetic LDL as targeted drug delivery vehicle |
08/28/2012 | US8252294 Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites |
08/28/2012 | US8252291 Bacteriocins and novel bacterial strains |
08/28/2012 | US8252288 Methods of using multimeric complexes of antigens and an adjuvant |
08/28/2012 | US8252278 Baculovirus expression system |
08/28/2012 | CA2508925C Product quality enhancement in mammalian cell culture processes for protein production |
08/28/2012 | CA2492470C Stable pharmaceutical composition comprising erythropoietin |
08/28/2012 | CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels |
08/28/2012 | CA2467383C Rapidly maturing fluorescent proteins and methods for using the same |
08/28/2012 | CA2454073C Mutations in ion channels |
08/28/2012 | CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
08/28/2012 | CA2447391C Substantially homogeneous bio-affecting material having a pre-determined ratio of transferrin to doxorubicin, its method of manufacture and its method of use |
08/28/2012 | CA2445578C Biological pacemaker comprising dominant-negative kir2.1aaa |
08/28/2012 | CA2432978C Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
08/28/2012 | CA2407240C Method for obtaining plants exhibiting enhanced resistance to water stress |
08/28/2012 | CA2399172C Cold-adapted equine influenza viruses |
08/28/2012 | CA2395632C A bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
08/28/2012 | CA2395589C Method for removing multimers of human serum albumin |
08/28/2012 | CA2319732C Methods for recovering polypeptides from plants and portions thereof |
08/23/2012 | WO2012112869A2 Targeted cancer therapy using ets transcriptional inhibitors |
08/23/2012 | WO2012112842A2 Compositions and methods for treating poliovirus |
08/23/2012 | WO2012112767A2 Collagen-targeted nanoparticles |
08/23/2012 | WO2012112434A1 Inhibiting aberrant blood vessel formation using retargeted endopeptidases |
08/23/2012 | WO2012112432A1 Methods of inhibiting aberrant blood vessel formation using opioid retargeted endopeptidases |
08/23/2012 | WO2012112422A1 Inhibiting aberrant blood vessel formation using growth factor retargeted endopeptidases |
08/23/2012 | WO2012112420A1 Treatments using psma ligand endopeptidases |
08/23/2012 | WO2012112411A1 Root-preferred promoter and methods of use |
08/23/2012 | WO2012111772A1 Polypeptide, isolated nucleic acid, recombinant vector, gene transfer kit, transformant, and method for regulating intracellular calcium signaling |
08/23/2012 | WO2012111438A1 Material for tissue regeneration, aqueous protein solution containing same, and method for gelling same |
08/23/2012 | WO2012110878A2 Method of diagnosing cancer and diagnosis kit using measurement of nk cell activity |
08/23/2012 | WO2012110856A1 Gmnac2 transcriptional gene and use thereof for enhancing plant tolerance to salt and/or drought |
08/23/2012 | WO2012110853A1 Gm wrky transcriptional gene and use thereof for enhancing plant tolerance to salt and/or drought |
08/23/2012 | WO2012110821A1 Protein secretion |
08/23/2012 | WO2012110636A2 Carrier peptides for cell delivery |
08/23/2012 | WO2012110596A1 Fusion protein for the treatment of immunologic or allergic reactions |
08/23/2012 | WO2012110570A1 Device and method for production and analysis of prions |
08/23/2012 | WO2012110500A1 Means and methods for improvement of synaptic dysfunction disorders |
08/23/2012 | WO2012109802A1 Immunodominant antigen of aspergillus and use thereof |
08/23/2012 | WO2012087039A3 Variant polypeptide having homoserine acetyltransferase activity and microorganism expressing same |
08/23/2012 | WO2012087038A3 Novel o-acetylhomoserine sulfhydrylase or variant thereof, and method for transforming methionine using same |
08/23/2012 | WO2012078313A3 Gb1 peptidic libraries and compounds, and methods of screening the same |
08/23/2012 | WO2012074285A3 Agent for stabilizing peptides or proteins |
08/23/2012 | WO2012074265A3 Composition for promoting the stability of stem cells |
08/23/2012 | WO2012061443A3 Compositions of a peptide targeting system for treating cancer |
08/23/2012 | WO2012057465A9 Salt tolerance sygt gene derived from synechocystis, and uses thereof |
08/23/2012 | WO2012037199A3 Methods for diagnosis and prognosis of inflammatory bowel disease using cytokine profiles |
08/23/2012 | WO2012006384A9 Rothia species gluten-degrading enzymes and uses thereof |
08/23/2012 | US20120216320 Method for modulating plant growth, nucleic acid molecules and polypeptides encoded thereof useful as modulating agent |
08/23/2012 | US20120216317 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves |
08/23/2012 | US20120216303 Novel therapeutic uses of human formyl peptide receptor antagonists |
08/23/2012 | US20120214976 Scalable Process for Protein Purification |
08/23/2012 | US20120214975 Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof |
08/23/2012 | US20120214974 Devices and Methods for the Purification, Isolation, Desalting or Buffer/Solvent Exchange of Substances |
08/23/2012 | US20120214972 Compositions and methods for modulating lymphocyte activity |
08/23/2012 | US20120214970 High Stability Streptavidin Mutant Proteins |
08/23/2012 | US20120214966 Multicolumn sequential separation process |
08/23/2012 | US20120214965 Glargine proinsulin and methods of producing glargine insulin analogs therefrom |
08/23/2012 | US20120214964 Liquid insulin compositions and methods of making the same |
08/23/2012 | US20120214963 Aspart proinsulin compositions and methods of producing aspart insulin analogs therefrom |
08/23/2012 | US20120214866 Treatment with cytokines |
08/23/2012 | US20120214747 Recombinant human alpha1- antitrypsin |
08/23/2012 | US20120214744 Polypeptides and nucleic acids for treating erbb2-dependent cancers |